Site Number - 1511 — Jefferson City, Missouri

Site Number - 1511 is a clinical research site located in Jefferson City, Missouri, United States 65109-6023.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Number - 1511 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Graves' Disease.

Sponsors: Immunovant Sciences GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jefferson City

Browse all research sites in Missouri · View every site in Jefferson City

• SSM Health St. Mary's Hospital - Jefferson City
• Capital Region Hospital
• MU Health Care Goldschmidt Cancer Center
• Capital Region Southwest Campus
• Capital Region Medical Center-Goldschmidt Cancer Center
• Jefferson City Medical Group
• Goldschmidt Cancer Center
• Novo Nordisk Investigational Site
• GSK Investigational Site
• Pfizer Investigational Site
• Research Site
• Capitol Comprehensive Cancer Care Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Number - 1511?

Site Number - 1511 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Number - 1511 conducted?

Site Number - 1511 has 1 clinical trials on record, with 1 currently active. Their work covers Graves' Disease.

Is Site Number - 1511 accredited by Crixeo Clinical Trials?

Site Number - 1511 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Number - 1511?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.